AEHR Test Systems buy BiotechBee
Start price
03.09.23
/
70%
€48.70
Target price
30.09.25
€60.00
Performance (%)
-54.17%
End price
02.12.23
€22.32
Summary
This prediction ended on 02.12.23 with a price of €22.32. Massive losses of -54.17% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AEHR Test Systems | 9.589% | 9.589% | 104.620% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% |
According to BiotechBee what are the pros and cons of AEHR Test Systems for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aehr Test Systems diskutieren
Buy mit Kursziel 60,0